Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ: QDEL )

27.78 +2.05 (+7.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Where QuidelOrtho Stands With Analysts
Via Benzinga
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
Raymond James analyst Andrew Cooper reiterates Strong Buy on QuidelOrtho Corporation (NASDAQ: QDEL),  
Via Benzinga
QuidelOrtho Reports Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho's Return on Invested Capital Overview
Via Benzinga
QuidelOrtho: Q1 Earnings Insights
Via Benzinga
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
Why QuidelOrtho Stock Popped by 5% on Friday
It looks like the company's first quarter is going to please investors greatly. 
Via The Motley Fool
Analyst Says QuidelOrtho's Interim Earnings Update Should 'Ease Some Investor Fears'
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
Something Happened In Biotech Last Week
Biotech stocks were more constructive last week with some sharp moves up. 
Via Talk Markets
QuidelOrtho Reports First Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why QuidelOrtho Stock Is Rising After Hours
QuidelOrtho Corp (NASDAQ: QDEL) shares are rising in extended trading Thursday after the company reported preliminary revenue results for  
Via Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday. 
Via Benzinga
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.